1. Home
  2. IIIV vs BDSX Comparison

IIIV vs BDSX Comparison

Compare IIIV & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo i3 Verticals Inc.

IIIV

i3 Verticals Inc.

N/A

Current Price

$18.98

Market Cap

304.5M

Sector

Technology

ML Signal

N/A

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$9.04

Market Cap

276.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IIIV
BDSX
Founded
2012
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
304.5M
276.2M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
IIIV
BDSX
Price
$18.98
$9.04
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$25.50
★ $39.00
AVG Volume (30 Days)
★ 283.3K
69.7K
Earning Date
11-17-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.24
N/A
Revenue
N/A
★ $88,499,000.00
Revenue This Year
$2.13
$26.35
Revenue Next Year
$4.98
$20.40
P/E Ratio
$79.25
★ N/A
Revenue Growth
N/A
★ 24.08
52 Week Low
$13.63
$5.26
52 Week High
$30.09
$31.97

Technical Indicators

Market Signals
Indicator
IIIV
BDSX
Relative Strength Index (RSI) 69.55 18.08
Support Level $18.47 N/A
Resistance Level $23.29 $16.66
Average True Range (ATR) 0.60 2.10
MACD 0.20 -0.96
Stochastic Oscillator 79.65 3.74

Price Performance

Historical Comparison
IIIV
BDSX

About IIIV i3 Verticals Inc.

i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: